| ADMA | Asymmetric Dimethylarginine |
| AGEs | advanced glycation end products |
| BH4 | tetrahydrobiopterin |
| COX-2 | Cyclooxygenase-2 |
| DKD | diabetic kidney disease |
| DPP-4 | Dipeptidyl peptidase-4 |
| EndMT | endothelial-mesenchymal transition |
| eNOS | endothelial nitric oxide synthase |
| EPC | endothelial progenitor cells |
| GECs | glomerular endothelial cells |
| GFR | glomerular filtration rate |
| GLP-1RA | glucagon-like peptide-1 receptor agonist |
| ICAM-1 | Intercellular Adhesion Molecule 1 |
| JNK | c-Jun NH2 terminal kinase |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NF-κB | nuclear factor-kappa B |
| NO | nitric oxide |
| PKC | protein kinase C |
| RAGE | receptor for advanced glycation endproducts |
| RAS | renin-angiotensin system |
| ROS | reactive oxygen species |
| SDF-1 | stromal cell-derived factor 1 |
| SGLT2 | Sodium glucose cotransporter 2 |
| TGF-β | transforming growth factor- β |
| VCAM-1 | vascular cell adhesion molecule 1 |
| VEGF | Vascular Endothelial Growth Factor |
| VEGFR2 | Vascular Endothelial Growth Factor Receptor 2 |